PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 7 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,716 | -31.0% | 22,000 | 0.0% | 0.00% | – |
| Q2 2023 | $2,488 | -31.5% | 22,000 | 0.0% | 0.00% | – |
| Q1 2023 | $3,630 | +52.3% | 22,000 | 0.0% | 0.00% | – |
| Q4 2022 | $2,383 | +138.3% | 22,000 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 22,000 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 22,000 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | – | 22,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HOME FEDERAL BANK OF TENNESSEE | 100,000 | $8,500 | 0.00% |
| LEE DANNER & BASS INC | 50,000 | $4 | 0.00% |
| LBMC INVESTMENT ADVISORS, LLC | 22,000 | $1,716 | 0.00% |
| Atlas Wealth LLC | 26,620 | $2,249 | 0.00% |
| ACADEMY CAPITAL MANAGEMENT INC/TX | 20,000 | $1,690 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |